Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

This repository is under review for potential modification in compliance with Administration directives.

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

Development Status

US Approved OTC

38

Possibly Marketed Outside US

4

All Match

Any Match

Exclude Selected

Exclude Selected

Primary Target

Methotrexate

38

Streptococcus mutans

38

T cell mediated immunity

38

Zinc transporter ZIP1

38

Zinc transporter ZIP2

38

All Match

Any Match

Exclude Selected

Exclude Selected

Highest Phase

Approved

39

All Match

Any Match

Exclude Selected

Exclude Selected

Approval Year

1921

38

2021

3

Unknown

1

All Match

Any Match

Exclude Selected

Exclude Selected

Condition

Unknown

41

Acute myeloid leukemia

38

Breast cancer

38

Caries

38

Diaper dermatitis

38

All Match

Any Match

Exclude Selected

Exclude Selected

Treatment Modality

Primary

39

Preventing

38

Secondary

38

All Match

Any Match

Exclude Selected

Exclude Selected

CNS Activity

CNS Active

38

All Match

Any Match

Exclude Selected

Exclude Selected

Originator

Smithson, R.

38

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Class

Chemical

40

Mixture

1

Protein

1

All Match

Any Match

Exclude Selected

Exclude Selected

Code System

FDA UNII

42

CAS

41

PUBCHEM

41

EPA CompTox

39

MERCK INDEX

27

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 1

ALIMENTARY TRACT AND METABOLISM

3

BLOOD AND BLOOD FORMING ORGANS

1

DERMATOLOGICALS

1

VARIOUS

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 2

MINERAL SUPPLEMENTS

2

ALL OTHER THERAPEUTIC PRODUCTS

1

BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS

1

MEDICATED DRESSINGS

1

OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 3

OTHER MINERAL SUPPLEMENTS

2

ALL OTHER THERAPEUTIC PRODUCTS

1

I.V. SOLUTION ADDITIVES

1

MEDICATED DRESSINGS

1

OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 4

Zinc

2

Detoxifying agents for antineoplastic treatment

1

Electrolyte solutions

1

Various alimentary tract and metabolism products

1

Zinc bandages

1

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Form

Salts, Hydrates, Esters, etc.

39

Principal Form

3

All Match

Any Match

Exclude Selected

Exclude Selected

Showing 1 - 10 of 42 results

First page disabled
Previous page disabled
1
Next page
Next page

ZINC CATION

13S1S8SF37

Export Data
Search for Structure

Status:

US Approved OTC

First marketed in 1921

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

respiratory burst

Streptococcus mutans

transformed cell apoptotic process

ultraviolet B-induced damage

T cell mediated immunity

Zinc transporter ZIP1

Zinc transporter ZIP2

Conditions:

Renal insufficiency

Ulcerative colitis

Acute myeloid leukemia

Zinc deficiency

Poison Ivy dermatitis

Diaper dermatitis

Gastrointestinal disorders

There is no available information related any biological and pharmaceutical application of ammonium tetrachlorozincate.

CUPRIC NITRATE HEXAHYDRATE

0HP2H86BS6

Export Data
Search for Structure

Status:

Possibly Marketed Outside US

First approved in 2021

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

membrane lipid catabolic process

Conditions:

Cupric nitrate (Copper(II) nitrate) is an inorganic compound that forms a blue crystalline solid. Copper(II) nitrate finds a variety of applications, the main one being its conversion to copper(II) oxide, which is used as catalyst for a variety of pr...

ocesses in organic chemistry. Its solutions are used in textiles and polishing agents for other metals. Copper nitrates are found in some pyrotechnics. It is often used in school laboratories to demonstrate chemical voltaic cell reactions. Strong oxidizing agent.

ZINC NITRATE

EDO66F5U49

Export Data
Search for Structure

Status:

Possibly Marketed Outside US

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

Aryl Hydrocarbon Receptor Pathway

Conditions:

Benign cervical lesions

Zinc nitrate is a colorless crystalline solid. It is used as a catalyst in the manufacture of other chemicals, in medicine, and in dyes, also as a fertilizer which helps plant growth and disease resistance.

ZINC DIBUTYRATE

VA6XH8E3JX

Export Data
Search for Structure

Status:

US Approved OTC

First marketed in 1921

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

respiratory burst

Streptococcus mutans

transformed cell apoptotic process

ultraviolet B-induced damage

T cell mediated immunity

Zinc transporter ZIP1

Zinc transporter ZIP2

Conditions:

Renal insufficiency

Ulcerative colitis

Acute myeloid leukemia

Zinc deficiency

Poison Ivy dermatitis

Diaper dermatitis

Gastrointestinal disorders

There is no available information related any biological and pharmaceutical application of ammonium tetrachlorozincate.

ZINC CITRATE DIHYDRATE

021IBV57IL

Export Data
Search for Structure

Status:

US Approved OTC

First marketed in 1921

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

respiratory burst

Streptococcus mutans

transformed cell apoptotic process

ultraviolet B-induced damage

T cell mediated immunity

Zinc transporter ZIP1

Zinc transporter ZIP2

Conditions:

Renal insufficiency

Ulcerative colitis

Acute myeloid leukemia

Zinc deficiency

Poison Ivy dermatitis

Diaper dermatitis

Gastrointestinal disorders

There is no available information related any biological and pharmaceutical application of ammonium tetrachlorozincate.

ZINC SUCCINATE

IY01B595GR

Export Data
Search for Structure

Status:

US Approved OTC

First marketed in 1921

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

respiratory burst

Streptococcus mutans

transformed cell apoptotic process

ultraviolet B-induced damage

T cell mediated immunity

Zinc transporter ZIP1

Zinc transporter ZIP2

Conditions:

Renal insufficiency

Ulcerative colitis

Acute myeloid leukemia

Zinc deficiency

Poison Ivy dermatitis

Diaper dermatitis

Gastrointestinal disorders

There is no available information related any biological and pharmaceutical application of ammonium tetrachlorozincate.

ZINC OROTATE DIHYDRATE

2R18GO895S

Export Data
Search for Structure

Status:

US Approved OTC

First marketed in 1921

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

respiratory burst

Streptococcus mutans

transformed cell apoptotic process

ultraviolet B-induced damage

T cell mediated immunity

Zinc transporter ZIP1

Zinc transporter ZIP2

Conditions:

Renal insufficiency

Ulcerative colitis

Acute myeloid leukemia

Zinc deficiency

Poison Ivy dermatitis

Diaper dermatitis

Gastrointestinal disorders

There is no available information related any biological and pharmaceutical application of ammonium tetrachlorozincate.

ZINC MONOCARBONATE

K8290PTQ4F

Export Data
Search for Structure

Status:

US Approved OTC

First marketed in 1921

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

respiratory burst

Streptococcus mutans

transformed cell apoptotic process

ultraviolet B-induced damage

T cell mediated immunity

Zinc transporter ZIP1

Zinc transporter ZIP2

Conditions:

Renal insufficiency

Ulcerative colitis

Acute myeloid leukemia

Zinc deficiency

Poison Ivy dermatitis

Diaper dermatitis

Gastrointestinal disorders

There is no available information related any biological and pharmaceutical application of ammonium tetrachlorozincate.

ZINC NITRIDE

7OOJ6UE14L

Export Data
Search for Structure

Status:

US Approved OTC

First marketed in 1921

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

respiratory burst

Streptococcus mutans

transformed cell apoptotic process

ultraviolet B-induced damage

T cell mediated immunity

Zinc transporter ZIP1

Zinc transporter ZIP2

Conditions:

Renal insufficiency

Ulcerative colitis

Acute myeloid leukemia

Zinc deficiency

Poison Ivy dermatitis

Diaper dermatitis

Gastrointestinal disorders

There is no available information related any biological and pharmaceutical application of ammonium tetrachlorozincate.

AMMONIUM PENTACHLOROZINCATE

3ILV18PW3Y

Export Data
Search for Structure

Status:

US Approved OTC

First marketed in 1921

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

respiratory burst

Streptococcus mutans

transformed cell apoptotic process

ultraviolet B-induced damage

T cell mediated immunity

Zinc transporter ZIP1

Zinc transporter ZIP2

Conditions:

Renal insufficiency

Ulcerative colitis

Acute myeloid leukemia

Zinc deficiency

Poison Ivy dermatitis

Diaper dermatitis

Gastrointestinal disorders

There is no available information related any biological and pharmaceutical application of ammonium tetrachlorozincate.

Showing 1 - 10 of 42 results

First page disabled
Previous page disabled
1
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1